PATENT CLAIM ANALYSIS

Application Number: 16046476
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "489000"]

Abstract:
A nimodipine injection concentrate and diluted formulation comprises nimodipine (base or salt), an effective amount of a hydrophilic surfactant, and a pharmaceutically acceptable carrier for injection which is an aqueous solution, an organic solvent, an oil, or a cyclodextrin, such that the nimodipine is substantially contained in a concentrated injection solution, suspension, emulsion or complex as a micelle or a colloidal particle or an inclusion complex and the formulation is stable and clear. In certain embodiments, the hydrophilic surfactant is polysorbate 80.

Claim (Index 17):
The method of  claim 15 , wherein the intravenous nimodipine dose is from about 2 to 10 mg administered every five hours.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 95.0
- Lexical Diversity: 1.69643
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15485813', '15638901', '15094461', '15754429', '13452033']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7701936395457079
- 35 USC 102 Novelty (BERT): 0.6488907675796128
- Combined Prediction Score: 0.7580633523490984
- Mean Citation Score: 402.348346
- Max Citation Score: 621.5713
- Similarity Product: 598.3740257197143

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test